VivianEMOlarteSVGutierrezAM. Insulin strategies for type 2 diabetes mellitus. Ann Pharmacother2004; 38:1916–23. DOI 10.1345/aph.1D635
2.
Medical guidelines for the management of diabetes mellitus. Endocr Pract2002;8(suppl 1):40–82.
3.
PolonskyKSSturisJeppe MBellG. Non—insulin-dependent diabetes mellitus—a genetically programmed failure of the beta cell to compensate for insulin resistance. N Engl J Med1996; 334:777–83.
4.
RaskinPAllenEHollanderPGabbayRAHuPBodeB., for the INITIATE Study Group. Initiating insulin therapy in type 2 diabetes: a comparison of biphasic and basal insulin analogs. Diabetes Care2005; 28:260–5.
5.
MaloneJKBaiSCampaigneBNReviriegoJAugendre-FerranteB. Targeting postprandial rather than fasting blood glucose results in better overall glycemic control in patient with type 2 diabetes (poster). Presented at: American Diabetes Association Annual Meeting, Orlando, June 2004.
6.
LuzioSDPeterRAJDunseathGJPauvadayVOwensDR. Comparison of biphasic insulin aspart (BIAsp30) and insulin glargine (IGlarg) during isoglycaemic clamp studies in persons with type 2 diabetes (abstract). Diabetes2004; 53(suppl 2):A136.